Supporting Innovative Ideas and Programs to Advance the Lysosomal Storage Disorder Community Worldwide
Genzyme is pleased to announce the fourth annual Patient Advocacy Leadership Awards (PAL Awards) program for non-profit organizations that serve the lysosomal storage disorder (LSD) patient community. The PAL Awards program seeks to spark innovation in disease awareness programs and patient support initiatives around the world. A total of $100,000 will be awarded through small, competitive grants to nonprofit, charitable patient organizations that seek funding for new initiatives that support the LSD community. All eligible patient organizations may apply for a maximum grant of $20,000.
As an independent voice in the lysosomal storage disease community, patient organizations play a vital role in providing leadership, resources and access to care and support for patients and their families around the world. We believe supporting their work is critical to optimizing patient care and meeting the ever-growing needs of the LSD community. Having partnered with patient organizations for more than 25 years, we are delighted to offer this highly successful program once again. Learn more.
"I believe that each institution should submit their dreams, even if it is simple or small, because only then we can make our ideas a tangible reality."